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Historical Perspectives
The Hematology fellowship program at Mayo Clinic Rochester began
in 1965 followed by the Oncology fellowship program in 1973. The two
programs later merged in 1990 and since that time, 115 fellows have
completed training (Table I). Mayo Clinic Jacksonville followed shortly
thereafter in 1996 and most recently, Mayo Clinic Scottsdale started its
program in 2006. Mayo Clinic is known for excellence in its three
shields: clinical practice, education, and research, all of which are
emphasized during the training program. Indeed, our fellowship com-
bines well-rounded clinical training with opportunities to work with
world-class faculty in a collegial environment. We believe that the
4-year fully funded fellowship program comprehensively prepares one
for a career in either academic medicine or group practice. The well-
balanced program offers a multidisciplinary approach to patients with
hematologic and oncologic disorders, clinical or basic science
research and opportunities to teach Mayo Medical School students
and internal medicine residents.
Clinical Practice
Mayo Clinic is a major national and international referral center whereby a
wide variety of oncologic and hematologic malignancies and benign hemato-
logic disorders, are seen by fellows during training under the supervision of
recognized experts, enhancing the educational experience and providing
patients with the best clinical care. Fellows also provide primary oncologic
care for patients with common hematologic and oncologic diseases as
Mayo Clinic serves as the primary referral center for the local, tri-state
region (Minnesota, Iowa, and Wisconsin). A unique feature of the program is
the autonomy and ﬂexibility afforded to our fellows to organize and schedule
their own continuity clinic patients. Throughout their training, fellows accu-
mulate patients to their continuity clinic panel, and are looked upon as the
patient’s primary oncologic or hematologic caregiver, with signiﬁcant clinical
decision responsibilities. This ensures that by the end of fellowship, they are
extremely well prepared for clinical practice. Fellows also obtain specialized
training during their time spent in our bone marrow transplant program,
TABLE I. Demographics of the Mayo Clinic Rochester
Hematology–Oncology Fellowship Program
Program features Details
Total no. of fellows at
present time
29
Outcomes of graduating
fellows in last 10 years
N 5 66
Academic institution 59% (39/66)
Academic-afﬁliated practice
a 20% (13/66)
Private practice 21% (14/66)
Peer-reviewed publications
by current fellows (per fellow)
135 (mean: 4.7; range 0–25)
Peer-reviewed publications by
fellows during fellowship
in last 10 years (per fellow)
297 (mean: 4.5; range: 0–32)
No. of ﬁrst year positions for 2011 9
No. of Hematology/Oncology
hospital beds
67
Inpatient admissions (2009) Hematology: 1514; Oncology: 1441
Outpatient new patient visits (2009) Hematology: 4943; Oncology: 5924
Cancer discharges
b 4,785 (ranked 3rd based on US
News and World Report on
Best Hospitals)
No. of faculty members Hematology: 45; Oncology: 37
aDeﬁned as a group practice that conducts independent clinical trials/research
and/or are afﬁliated with a residency program or medical school.
bAll Medicare inpatients who received medical or surgical care for a cancer diag-
nosis in 2005–2007.
Figure 1. Gonda building in downtown Rochester where the outpatient practice
is located. (Reproduced with permission from Mayo Foundation for medical educa-
tion and research.)
Figure 2. Simulation workshop in the anatomy procedural skills laboratory to
teach bone marrow biopsies and aspirates to ﬁrst-year fellows. (Reproduced with
permission from Anatomy Laboratory, Mayo Clinic, Rochester.)
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plants in 2009. As a regional transplant center, the program continues to
expand with the introduction of umbilical cord transplantation in 2009 and an
increase in autologous and allogeneic transplants. The outpatient practice is
based at the downtown Mayo Clinic facility (Figure 1), while the inpatient
Hematology and Oncology services are located at the 794-bed Rochester
Methodist Hospital and consult services at the 1265-bed St. Mary’s Hospital,
all of which have fully computerized and integrated medical records.
Education
Mayo Clinic’s Hematology and Oncology fellowship program utilizes the
state-of-the-art multidisciplinary simulation center and anatomy procedure
skills laboratory (Figure 2), to train fellows and other medical staff in proce-
dures and problem-solving clinical scenarios. In addition to inpatient and out-
patient clinical rotations, fellows rotate through other departments such as
Radiation Oncology, Medical Genetics, Palliative Care and a variety of labo-
ratories including, Surgical Pathology, Hematopathology, Cytogenetics,
Transfusion Medicine, and Coagulation ensuring comprehensive training.
Educational sessions for fellows include a thrice-weekly core lecture series,
journal clubs, board review sessions, hematopathology and departmental
conferences, medical grand rounds, and annual in-training examinations in
Hematology and Oncology to prepare fellows for the board exams. This has
proved to be successful as evident from the high-pass rate achieved in the
Hematology and Oncology boards.
Research
Mayo Clinic is a National Cancer Institute (NCI)-designated comprehen-
sive cancer center, and therefore provides a rich menu of research opportu-
nities for fellows to pursue during their 18–22 months of dedicated research
time. Multiple programs in respective solid tumor groups, women’s cancers,
drug development, supportive care, and hematologic malignancies provide
fellows with opportunities for either laboratory-based or clinically based
research. The institution conducts several weekly cancer-related conferences,
thereby allowing fellows to learn of ongoing research efforts and to meet face-
to-face with investigators who could serve as potential mentors. There are
over 300 active clinical trials open at any one time, and Mayo Clinic serves
as the primary research base for the NCI-funded North Central Cancer
Treatment Group, the Phase II Consortium (a drug development program),
seven different highly competitive SPORE grants (specialized program of
research development) in brain, breast, lymphoma, myeloma, ovary, pan-
creas, and prostate, a community clinical oncology program grant, and a
cancer prevention network. Opportunities for basic science, translational,
and clinical research are robust on the Mayo Clinic campus. Fellows are
involved in writing and development of clinical trials and past and current fel-
lows have been very successful in publishing their research in peer-reviewed
journals and presenting abstracts and oral presentations at national and
international conferences (Table I). Fellows have the opportunity to obtain a
Masters in clinical research from the Mayo School of Graduate Medical Edu-
cation, during their 4-year program. In addition to the conventional track, a
number of our fellows have trained in the Mayo Clinical-Investigator Pro-
gram, which is designed to prepare leaders in academic medicine. Many of
our fellows have successfully obtained appointments in various academic
institutions, nationally and internationally, and have received NCI funding
and National Institute of Health Career Development awards (K-awards).
Broadly trained and well-mentored, fellows at the Mayo Clinic possess a
diverse set of skills which allow them to achieve excellence in all types of
academic or community-based practice. Our fellows, exposed to the princi-
ples of the founding fathers of the Mayo Clinic, perpetuate their legacy of
dedication to clinical care, research, and education.
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